Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cryovasc GmbH is currently managing 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct art unit, indicating a specific technical focus for the company's mechanical innovations. The prosecution is handled by 1 distinct examiner, providing a single point of contact for the pending matter. This one-to-one ratio between the examiner and the action suggests a straightforward prosecution path.
FLANAGAN, BEVERLY MEINDL is the busiest examiner for this portfolio, currently overseeing the 1 pending office action. With the examiner and art unit involved, the prosecution strategy is highly centralized within the Medical Devices & Mechanical Engineering sector. This concentration means that the pending office action is subject to the specific examination criteria of FLANAGAN, BEVERLY MEINDL. The alignment of 1 distinct art unit with the pending action suggests a well-defined scope for the company's current intellectual property efforts. Practitioners should focus on the specific examination style of FLANAGAN, BEVERLY MEINDL within the art unit. This centralized approach allows for a consistent legal strategy across the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLANAGAN, BEVERLY MEINDL | 1 | 73.6% | +20.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18860663 | Medical Cryotherapy Device with Heat Transfer Body | FLANAGAN, BEVERLY MEINDL | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18860663 | Medical Cryotherapy Device with Heat Transfer Body | FLANAGAN, BEVERLY MEINDL | 3794 | §112 | Non-Final OA | — | Pending | Oct 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCryovasc GmbH has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Beverly Meindl Flanagan has the most, with 1 of Cryovasc GmbH's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.